<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 02 Feb 2017 08:27:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  8-K        Bioverativ Inc.           For: Jan 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bioverativ+Inc.+++++++++++For%3A+Jan+31/12490178.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bioverativ+Inc.+++++++++++For%3A+Jan+31/12490178.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Bioverativ+Inc.+++++++++++For%3A+Jan+31/12490178.html</guid>
   <pubDate>Thu, 02 Feb 2017 08:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Swedish Orphan Biovitrum AB - Long-term Safety and Efficacy Data of Extended Half-life Therapy Alprolix in Children With Haemophilia B Published in The Lancet Haematology</title>
   <link>http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24904667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOBI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTUY</category>
   	  </item>
  <item>
   <title>Swedish Orphan Biovitrum AB - Long-term Safety and Efficacy Data of Extended Half-life Therapy Alprolix in Children With Haemophilia B Published in The Lancet Haematology</title>
   <link>http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24904667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOBI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTUY</category>
   	  </item>
  <item>
   <title>Swedish Orphan Biovitrum AB - Long-term Safety and Efficacy Data of Extended Half-life Therapy Alprolix in Children With Haemophilia B Published in The Lancet Haematology</title>
   <link>http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24904667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOBI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTUY</category>
   	  </item>
  <item>
   <title>Swedish Orphan Biovitrum AB - Long-term Safety and Efficacy Data of Extended Half-life Therapy Alprolix in Children With Haemophilia B Published in The Lancet Haematology</title>
   <link>http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24904667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOBI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTUY</category>
   	  </item>
  <item>
   <title>Swedish Orphan Biovitrum AB - Long-term Safety and Efficacy Data of Extended Half-life Therapy Alprolix in Children With Haemophilia B Published in The Lancet Haematology</title>
   <link>http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Swedish+Orphan+Biovitrum+AB+-+Long-term+Safety+and+Efficacy+Data+of+Extended+Half-life+Therapy+Alprolix+in+Children+With+Haemophilia+B+Published+in+The+Lancet+Haematology/12489866.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:46:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.24904667</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOBI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTUY</category>
   	  </item>
  <item>
   <title>UPDATE: Morgan Stanley Starts Bioverativ Inc (BIVV) at Underweight</title>
   <link>http://www.streetinsider.com/New+Coverage/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:15:55 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>UPDATE: Morgan Stanley Starts Bioverativ Inc (BIVV) at Underweight</title>
   <link>http://www.streetinsider.com/New+Coverage/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/New+Coverage/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:15:55 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>UPDATE: Morgan Stanley Starts Bioverativ Inc (BIVV) at Underweight</title>
   <link>http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:15:55 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>UPDATE: Morgan Stanley Starts Bioverativ Inc (BIVV) at Underweight</title>
   <link>http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Morgan+Stanley+Starts+Bioverativ+Inc+%28BIVV%29+at+Underweight/12488880.html</guid>
   <pubDate>Thu, 02 Feb 2017 07:15:55 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Form  4          Bioverativ Inc.           For: Feb 01  Filed by: BIOGEN INC.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bioverativ+Inc.+++++++++++For%3A+Feb+01++Filed+by%3A+BIOGEN+INC./12488255.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bioverativ+Inc.+++++++++++For%3A+Feb+01++Filed+by%3A+BIOGEN+INC./12488255.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bioverativ+Inc.+++++++++++For%3A+Feb+01++Filed+by%3A+BIOGEN+INC./12488255.html</guid>
   <pubDate>Wed, 01 Feb 2017 17:22:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Form  3          Bioverativ Inc.           For: Feb 01  Filed by: Duvall Diantha</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Bioverativ+Inc.+++++++++++For%3A+Feb+01++Filed+by%3A+Duvall+Diantha/12487238.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Bioverativ+Inc.+++++++++++For%3A+Feb+01++Filed+by%3A+Duvall+Diantha/12487238.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Bioverativ+Inc.+++++++++++For%3A+Feb+01++Filed+by%3A+Duvall+Diantha/12487238.html</guid>
   <pubDate>Wed, 01 Feb 2017 16:12:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Spinoffs/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Biogen (BIIB) Completes Separation of Bioverativ (BIVV)</title>
   <link>http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Biogen+%28BIIB%29+Completes+Separation+of+Bioverativ+%28BIVV%29/12483904.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:33:54 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Bioverativ Launches as Global Biotechnology Company Dedicated to Meaningful Progress in Hemophilia</title>
   <link>http://www.streetinsider.com/Press+Releases/Bioverativ+Launches+as+Global+Biotechnology+Company+Dedicated+to+Meaningful+Progress+in+Hemophilia/12483864.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Bioverativ+Launches+as+Global+Biotechnology+Company+Dedicated+to+Meaningful+Progress+in+Hemophilia/12483864.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Bioverativ+Launches+as+Global+Biotechnology+Company+Dedicated+to+Meaningful+Progress+in+Hemophilia/12483864.html</guid>
   <pubDate>Wed, 01 Feb 2017 07:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	  </item>
  <item>
   <title>Sobi and Bioverativ to Reveal new Long-term Safety and Efficacy Data of Elocta® and Alprolix® at EAHAD</title>
   <link>http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html</guid>
   <pubDate>Wed, 01 Feb 2017 03:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOBI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTUY</category>
   	  </item>
  <item>
   <title>Sobi and Bioverativ to Reveal new Long-term Safety and Efficacy Data of Elocta® and Alprolix® at EAHAD</title>
   <link>http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html</guid>
   <pubDate>Wed, 01 Feb 2017 03:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOBI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTUY</category>
   	  </item>
  <item>
   <title>Sobi and Bioverativ to Reveal new Long-term Safety and Efficacy Data of Elocta® and Alprolix® at EAHAD</title>
   <link>http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Sobi+and+Bioverativ+to+Reveal+new+Long-term+Safety+and+Efficacy+Data+of+Elocta%C2%AE+and+Alprolix%C2%AE+at+EAHAD/12482894.html</guid>
   <pubDate>Wed, 01 Feb 2017 03:09:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BIVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">BIVVV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SOBI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SWTUY</category>
   	  </item>
 </channel>
</rss>
